Form 4 for GALT GALECTIN THERAPEUTICS INC
Accepted 2025-12-19 00:00:00 ET · period of report 2025-12-17 · accession 0001133416-25-000069 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-12-19 | 2025-12-17 | GALT | Jamil Khurram | Chief Medical Off | M - OptEx | $2.37 | +15.0K | 8,500 | New | +$35.5K |
| DMT | 2025-12-19 | 2025-12-17 | GALT | Jamil Khurram | Chief Medical Off | S - Sale+OE | $7.04 | -19.4K | 0 | -100% | -$136.9K |
| DMT | 2025-12-19 | 2025-12-17 | GALT | Jamil Khurram | Chief Medical Off | M - OptEx | $0.00 | -15.0K | 102.0K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-17 | M | A | 6,463 | $2.20 | 6,463 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-17 | S | D | 8,500 | $7.04 | 0 | D | — | — | (F2) The shares were sold in multiple transactions at prices ranging from $7.00 to $7.11. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| 3 | Common | Common Stock | 2025-12-17 | M | A | 8,500 | $2.50 | 8,500 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-17 | S | D | 6,463 | $7.04 | 0 | D | — | — | (F2) The shares were sold in multiple transactions at prices ranging from $7.00 to $7.11. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| 5 | Common | Common Stock | 2025-12-17 | S | D | 4,479 | $7.04 | 0 | D | — | — | (F2) The shares were sold in multiple transactions at prices ranging from $7.00 to $7.11. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| 6 | Derivative | Stock option (right to buy) | 2025-12-17 | M | D | 8,500 | $0.00 | 50,000 | D | $2.50 · 2025-07-31 to 2034-08-01 | 8,500 Common Stock | (F4) The options vest as follows: 25,000 on each of October 31, 2024, January 31, 2025, April 30, 2025, and July 31, 2025. |
| 7 | Derivative | Stock option (right to buy) | 2025-12-17 | M | D | 6,463 | $0.00 | 102,037 | D | $2.20 · 2025-03-31 to 2034-03-20 | 6,364 Common Stock | (F3) The options vest as follows: 50,000 on March 11, 2025, with 50,000 scheduled to vest on each of March 11, 2026 and March 11, 2027. |